Neogen Chemicals Limited (NSE:NEOGEN)
India
· Delayed Price · Currency is INR | Market Cap | 45.50B |
| Revenue (ttm) | 8.18B |
| Net Income (ttm) | 197.40M |
| Shares Out | 27.38M |
| EPS (ttm) | 7.48 |
| PE Ratio | 222.14 |
| Forward PE | 84.28 |
| Dividend | 1.00 (0.06%) |
| Ex-Dividend Date | Sep 19, 2025 |
| Volume | 29,664 |
| Average Volume | 138,696 |
| Open | 1,663.00 |
| Previous Close | 1,661.70 |
| Day's Range | 1,643.10 - 1,699.00 |
| 52-Week Range | 966.70 - 1,797.00 |
| Beta | 0.22 |
| RSI | 71.92 |
| Earnings Date | Apr 30, 2026 |
About Neogen Chemicals
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, li... [Read more]
Financial Performance
In fiscal year 2025, Neogen Chemicals's revenue was 7.78 billion, an increase of 12.58% compared to the previous year's 6.91 billion. Earnings were 348.30 million, a decrease of -2.30%.
Financial StatementsNews
Neogen Chemicals Ltd (BOM:542665) Q3 2026 Earnings Call Highlights: Strategic Growth Amidst ...
Neogen Chemicals Ltd (BOM:542665) Q3 2026 Earnings Call Highlights: Strategic Growth Amidst Challenges
Q3 2026 Neogen Chemicals Ltd Earnings Call Transcript
Q3 2026 Neogen Chemicals Ltd Earnings Call Transcript
Neogen Chemicals Transcript: Q3 25/26
Q3 FY26 saw 9% revenue growth and margin expansion, though PAT was impacted by transitory costs from the Dahej fire and Neogen Ionics ramp-up. Battery chemical guidance for FY27 remains at INR 400-500 crore, with major capacity expansions and customer approvals on track.
Neogen Chemicals Ltd (BOM:542665) Q2 2026 Earnings Call Highlights: Strategic Growth Amid ...
Neogen Chemicals Ltd (BOM:542665) Q2 2026 Earnings Call Highlights: Strategic Growth Amid Operational Challenges
Q2 2026 Neogen Chemicals Ltd Earnings Call Transcript
Q2 2026 Neogen Chemicals Ltd Earnings Call Transcript
Neogen Chemicals Transcript: Q2 25/26
Q2 FY 2026 delivered 8% revenue growth and 16% gross profit improvement, but profitability was constrained by higher costs from a plant outage and delayed battery chemical demand. Battery Chemicals revenue guidance was revised down for FY 2026, with strong growth expected from FY 2027 as customer approvals and industry ramp-up materialize.
Neogen Chemicals shares jump over 3% after subsidiary signs JVA with Japan’s Morita Investment
Neogen Chemicals shares rose more than 3% in Monday’s trade after its wholly owned subsidiary, Neogen Ionics Limited (NIL), signed a Joint Venture Agreement with Morita Investment Limited (MIL), a sub...
Neogen Chemicals’ subsidiary Neogen Ionics signs JVA with Japan’s Morita Investment for lithium-Ion battery materials
Neogen Chemicals Limited has informed that its wholly owned subsidiary, Neogen Ionics Limited (NIL), has executed a Joint Venture Agreement (JVA) with Morita Investment Limited (MIL), a wholly owned s...
Neogen Chemicals shares drop over 3% as Q1 net profit declines 10.5% YoY to Rs 10.3 crore
Neogen Chemicals Ltd shares slipped over 3% in morning trade on August 4 after the company reported a muted set of numbers for the first quarter of FY26. The stock opened at ₹1,539.80 and touched an i...
Neogen Chemicals Transcript: Q1 25/26
Q1 FY26 saw resilient performance with 4% revenue growth despite Dahej plant outage, strong base business volumes, and initial Neogen Ionics sales. Major CapEx and insurance recovery are on track, with robust long-term outlook and growing global demand for non-China battery materials.
Neogen Chemicals board approves Rs 200 crore fundraise via NCDs
Neogen Chemicals Limited has announced that its Board of Directors approved a fundraise of up to ₹200 crore through the issuance of fully paid, secured, listed, rated, redeemable, rupee-denominated no...
Neogen Chemicals Transcript: Q4 24/25
FY25 saw 13% revenue and 24% EBITDA growth despite a fire incident and global pricing headwinds. Battery chemicals expansion and a JV with Morita position the company for strong growth, with FY26 revenue guidance at INR 750–850 crore and battery segment targeting INR 300 crore.
Neogen Chemicals shares drop 3% after fire incident at Dahej SEZ plant
Shares of Neogen Chemicals Ltd fell 3% on March 5, 2025, after the company reported a fire incident at its Dahej SEZ plant around 12:30 AM IST. The cause of the fire is still under investigation. Due ...
Neogen Chemicals reports major fire incident at Dahej SEZ plant
Neogen Chemicals Limited reported a fire incident at its Dahej SEZ plant on March 5, 2025, at around 12:30 AM IST. The cause of the fire is under investigation, but due to the prompt response of the s...
Neogen Chemicals shares jump 3% as net profit rises 844.34% YoY in Q3
Neogen Chemicals shares surged 3% following impressive Q3 results. As of 9:57 AM, the shares were trading 3.05% higher at Rs 2,058.00. The company reported a massive 844.34% increase in net profit, wh...
Neogen Chemicals Transcript: Q3 24/25
Q3 FY25 saw 22% revenue and 71% EBITDA growth, driven by BuLi Chem ramp-up and strong organic performance. Battery chemicals revenue guidance for FY25 was revised down due to delayed approvals, but FY26 outlook remains robust with major capacity expansions and strong customer engagement.
Neogen Chemicals Ltd (BOM:542665) Q2 2025 Earnings Call Highlights: Strong Revenue Growth ...
Neogen Chemicals Ltd (BOM:542665) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges
Q2 2025 Neogen Chemicals Ltd Earnings Call Transcript
Q2 2025 Neogen Chemicals Ltd Earnings Call Transcript
Neogen Chemicals Transcript: Q2 24/25
Q2 FY25 saw 20% revenue growth and 33% EBITDA rise, driven by strong organic segment and BuLi Chemicals. Battery chemical revenue for FY25 is guided at INR 50–75 crore, with FY26 expected at INR 400–500 crore. CapEx and capacity expansions are on track.
Neogen Chemicals share price surges over 8% today after Avendus initiates Buy call, expects 111% upside in stock
Avendus SPARK has initiated coverage on Neogen Chemicals, giving it a ‘Buy’ rating with a one-year target price of ₹3,600 and a long-term three-year target price of ₹4,500. The stock is currently trad...
Neogen Chemicals share jumps 4% in morning trade
Neogen Chemicals’s share witnessed a significant surge on the National Stock Exchange (NSE) today, jumping more than 4% in the morning trade. The stock stock opened at ₹1,513.80. The stock hit a day h...
Neogen Chemicals Transcript: Q1 24/25
Q1 FY25 saw 9% revenue and 18% profit growth, driven by strong organic performance and battery chemical expansion. Capacity ramp-up and long-term contracts are on track, with positive cash flow and robust demand for non-Chinese supply.